Pharma BD Deal Intelligence

Sanofi SA / Ablynx NV

2018 · Acquisition/Merger · $4.8B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

67

Largely worked — most objectives met.

Sanofi acquired Ablynx for $4.8B, a Belgian biotechnology firm.

Key facts

Announced Jan 26, 2018
Closed Jun 12, 2018
Deal value $4.8B
Deal type Acquisition/Merger
Therapeutic area Immunology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals